3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
fludarabine
15
Specimen Handling
14
Cyclophosphamide
13
Biopsy
12
fludarabine phosphate
10
Cytarabine
10
Mycophenolic Acid
9
Melphalan
9
Busulfan
9
venetoclax
8
Whole-Body Irradiation
8
Tacrolimus
8
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Azacitidine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
X-Rays
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Thiotepa
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.